Trials / Enrolling By Invitation
Enrolling By InvitationNCT07221695
Embolization Strategies for Pelvic Venous Disorders: Foam + Glue vs Foam + Coils
Foam Plus Glue Versus Foam Plus Coils for Ovarian Vein Embolization in the Treatment of Pelvic Venous Disorders:
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Kafrelsheikh University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Foam Plus Glue Versus Foam Plus Coils for Ovarian Vein Embolization in the Treatment of Pelvic Venous Disorders: A Randomized Controlled Trial
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Foam + N-butyl Cyanoacrylate | 3% polidocanol (Aethoxysklerol®, Kreussler Pharma), mixed with room air in a 1:4 ratio (1 mL polidocanol to 4 mL air) using the Tessari double-syringe technique, creating a dense and stable foam. |
| OTHER | Combined Foam Sclerotherapy and Detachable Coil Embolization | polidocanol foam (as above), subsequently, detachable platinum fibered coils - specifically Interlock™ (Boston Scientific) or Concerto™ (Medtronic) |
Timeline
- Start date
- 2025-08-25
- Primary completion
- 2025-08-25
- Completion
- 2025-12-25
- First posted
- 2025-10-28
- Last updated
- 2025-10-28
Locations
1 site across 1 country: Egypt
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07221695. Inclusion in this directory is not an endorsement.